Last updated: March 29, 2025
Sponsor: Tanta University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Anesthesia
Treatment
General anesthesia
Bupivacaine 0.5%
Clinical Study ID
NCT06904703
36265MD311/11/24
Ages > 75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Aged >75 years.
Both sexes.
American Society of Anesthesiologists (ASA) classification I-III.
Undergoing total hip arthroplasty under general anesthesia.
Exclusion
Exclusion Criteria:
Patient refusal.
Body mass index (BMI) > 30 kg/m2.
Allergy to local anesthesia drugs.
Infection at the site of intervention.
Coagulopathies.
Preexisting advanced diseases of the kidney or liver.
Study Design
Total Participants: 120
Treatment Group(s): 2
Primary Treatment: General anesthesia
Phase:
Study Start date:
December 01, 2024
Estimated Completion Date:
November 01, 2026
Study Description
Connect with a study center
Faculty of Medicine
Tanta, 31527
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.